Retatrutide
TRIUMPH-9
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 600
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Retatrutide Dose Escalation 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Retatrutide Dose Escalation 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Retatrutide Dose Escalation 3 | Obesity or overweight | n/r | n/r | n/r | n/r |